Suppr超能文献

针对一组源自H-2b的T细胞淋巴瘤的杂种抗性的胸腺非依赖性

Thymus independence of hybrid resistance against a panel of T-cell lymphomas of H-2b origin.

作者信息

Klein G O, Kärre K, Kiessling R, Klein G

出版信息

Int J Cancer. 1982 Nov 15;30(5):659-62. doi: 10.1002/ijc.2910300518.

Abstract

Adult thymectomy, followed by whole-body irradiation and reconstitution with fetal liver, was performed to study the T-cell dependence of F1 hybrid resistance to a panel of lymphomas of H-2b origin. Previously, the pattern of hybrid resistance against the same lymphomas was found to correlate with the pattern of NK-activity in a spectrum of F1 hybrids (Kiessling et al., 1975). We now show that hybrid resistance against three lymphomas of C57BL/6 origin, P-52-127-166, RBL-5 and EL-4 and against YLD, of C57L origin, is expressed in the absence of thymus. In another series of experiments, the effectors responsible for hybrid resistance to the transplanted lymphoma EL-4 were studied by reconstituting thymectomized and non-thymectomized C57BL mice with syngeneic bone marrow from NK-deficient beige mutant or wild-type C57BL donors. While the recipients of beige bone marrow had a clearly reduced tumor resistance, thymectomy did not decrease resistance further. This study supports the hypothesis that resistance to these lymphomas in F1 hybrids as well as in syngeneic mice is mainly mediated by natural killer cells.

摘要

进行成年胸腺切除术,随后进行全身照射并用胎肝进行重建,以研究F1杂种对一组H-2b来源淋巴瘤的T细胞依赖性。此前,已发现针对相同淋巴瘤的杂种抗性模式与一系列F1杂种中的NK活性模式相关(基斯林等人,1975年)。我们现在表明,在没有胸腺的情况下,F1杂种对三种C57BL/6来源的淋巴瘤P-52-127-166、RBL-5和EL-4以及对C57L来源的YLD具有抗性。在另一系列实验中,通过用来自NK缺陷的米色突变体或野生型C57BL供体的同基因骨髓重建胸腺切除和未胸腺切除的C57BL小鼠,研究了对移植淋巴瘤EL-4的杂种抗性的效应细胞。虽然米色骨髓受体的肿瘤抗性明显降低,但胸腺切除术并未进一步降低抗性。这项研究支持了这样的假设,即F1杂种以及同基因小鼠对这些淋巴瘤的抗性主要由自然杀伤细胞介导。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验